TarGeT-SCR TarGeT: TARGETED PEDIATRIC HIGH-GRADE GLIOMA THERAPY Molecularly-Guided Phase II Umbrella Trial for Children, Adolescents, and Young Adults Newly Diagnosed with High-Grade Glioma (HGG), including Diffuse Intrinsic Pontine Glioma (DIPG)
Clinical Trial Grant
Awarded By
Research Institute at Nationwide Children's Hospital
Start Date
January 23, 2026
End Date
January 22, 2027
Awarded By
Research Institute at Nationwide Children's Hospital
Start Date
January 23, 2026
End Date
January 22, 2027